We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Klinické a biologické prognostické faktory u maligních lymfomů.
- Authors
V., Procházka; M., Jarošová; Z., Prouzová; M., Geierová; V., Papajík; K., Indrák
- Abstract
Malignant lymphomas represent a clinically, biologically and genetically varied group of neoplasms. Moreover, the last decade has provided modern haemato-oncology with numerous novel biologically active drugs that have extended therapeutic options and changed our patients' lives. The era of personalized medicine places new demands on physicians' decision-making processes. A confident prediction of the patient's outlook is now an indispensable tool for selecting treatment strategy. Predictive tools, or predictive factors, hand in hand with changes in therapy, have undergone dramatic development. Previous clinical schemes and prognostic indices postulated in the era prior to the introduction of immunotherapy and intensive treatment protocols have limited information value today. Novel prognostic factors are better at reflecting the nature of tumours themselves, allowing estimation of chemo-immunotherapy effectiveness and take into consideration the immune interaction between a tumour and the patient's organism. Modern molecular cytogenetic and immunohistochemi-cal methods yield important additional prognostic information. The article aims at providing a review of currently used predictive tools, from traditional scores to novel findings in the field of tumour cytogenetics and immunogenomics.
- Subjects
LYMPHOMAS; LYMPHATIC diseases; TUMORS; PATHOLOGY; HEMATOLOGY
- Publication
Transfusiology & Haematology Today / Transfuze a Hematologie Dnes, 2013, Vol 19, Issue 2, p76
- ISSN
1213-5763
- Publication type
Article